In male melanoma, AR-positive patients exhibited worse survival rates compared to AR-negative patients, attributed to the ability of AR to enhance melanoma cell invasion through modulation of the MITF-AXL signaling pathway [33]. This evidence concerns the gene MITF and melanoma.